1. Home
  2. STVN vs MAIN Comparison

STVN vs MAIN Comparison

Compare STVN & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • MAIN
  • Stock Information
  • Founded
  • STVN 1949
  • MAIN 2007
  • Country
  • STVN Italy
  • MAIN United States
  • Employees
  • STVN N/A
  • MAIN N/A
  • Industry
  • STVN Containers/Packaging
  • MAIN Finance/Investors Services
  • Sector
  • STVN Consumer Discretionary
  • MAIN Finance
  • Exchange
  • STVN Nasdaq
  • MAIN Nasdaq
  • Market Cap
  • STVN 5.7B
  • MAIN 4.8B
  • IPO Year
  • STVN 2021
  • MAIN 2007
  • Fundamental
  • Price
  • STVN $21.77
  • MAIN $54.34
  • Analyst Decision
  • STVN Buy
  • MAIN Hold
  • Analyst Count
  • STVN 6
  • MAIN 5
  • Target Price
  • STVN $25.08
  • MAIN $52.60
  • AVG Volume (30 Days)
  • STVN 338.6K
  • MAIN 651.3K
  • Earning Date
  • STVN 05-08-2025
  • MAIN 05-08-2025
  • Dividend Yield
  • STVN 0.27%
  • MAIN 7.30%
  • EPS Growth
  • STVN N/A
  • MAIN 11.91
  • EPS
  • STVN 0.45
  • MAIN 5.85
  • Revenue
  • STVN $1,143,012,735.00
  • MAIN $541,026,000.00
  • Revenue This Year
  • STVN $8.60
  • MAIN $5.03
  • Revenue Next Year
  • STVN $10.43
  • MAIN $2.76
  • P/E Ratio
  • STVN $48.77
  • MAIN $9.06
  • Revenue Growth
  • STVN 1.72
  • MAIN 8.12
  • 52 Week Low
  • STVN $16.56
  • MAIN $45.00
  • 52 Week High
  • STVN $28.77
  • MAIN $63.32
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.72
  • MAIN 48.45
  • Support Level
  • STVN $21.13
  • MAIN $51.24
  • Resistance Level
  • STVN $22.46
  • MAIN $54.92
  • Average True Range (ATR)
  • STVN 1.33
  • MAIN 2.44
  • MACD
  • STVN 0.12
  • MAIN 0.29
  • Stochastic Oscillator
  • STVN 86.32
  • MAIN 89.32

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

Share on Social Networks: